| Effectiveness of face mask or respirator use in indoor public settings for prevention of SARS-CoV-2 infection—California, February–December 2021 KL Andrejko MMWR. Morbidity and mortality weekly report 71, 2022 | 186* | 2022 |
| School closures reduced social mixing of children during COVID-19 with implications for transmission risk and school reopening policies JR Head, KL Andrejko, Q Cheng, PA Collender, S Phillips, A Boser, ... Journal of the Royal Society Interface 18 (177), 20200970, 2021 | 80* | 2021 |
| Prevention of Coronavirus Disease 2019 (COVID-19) by mRNA-Based Vaccines Within the General Population of California KL Andrejko, J Pry, JF Myers, NP Jewell, J Openshaw, J Watt, S Jain, ... Clinical Infectious Diseases, 2021 | 64* | 2021 |
| Antimicrobial resistance in paediatric Streptococcus pneumoniae isolates amid global implementation of pneumococcal conjugate vaccines: a systematic review and meta-regression … K Andrejko, B Ratnasiri, WP Hausdorff, R Laxminarayan, J Lewnard The Lancet Microbe, 2021 | 58 | 2021 |
| Prevalence and clinical profile of severe acute respiratory syndrome coronavirus 2 infection among farmworkers, California, USA, June–November 2020 JA Lewnard, AM Mora, O Nkwocha, K Kogut, SA Rauch, N Morga, ... Emerging infectious diseases 27 (5), 1330, 2021 | 32* | 2021 |
| Predictors of SARS-CoV-2 infection following high-risk exposure KL Andrejko, J Pry, J Myers, K Openshaw, J Watt, N Birkett, JL DeGuzman, ... Clinical Infectious Diseases, 2021 | 31* | 2021 |
| Determinants of uptake of intermittent preventive treatment during pregnancy: a review E Roman, K Andrejko, K Wolf, M Henry, S Youll, L Florey, E Ferenchick, ... Malaria Journal 18, 1-9, 2019 | 27 | 2019 |
| The safety of atovaquone-proguanil for the prevention and treatment of malaria in pregnancy: A systematic review KL Andrejko, RC Mayer, S Kovacs, E Slutsker, E Bartlett, KR Tan, ... Travel medicine and infectious disease 27, 20-26, 2019 | 23 | 2019 |
| Model-based assessment of SARS-CoV-2 Delta variant transmission dynamics within partially vaccinated K-12 school populations JR Head, KL Andrejko, JV Remais The Lancet Regional Health–Americas 5, 2022 | 17 | 2022 |
| Health-Economic Value of Vaccination Against Group A Streptococcus in the United States K Andrejko, LK Whittles, JA Lewnard Clinical Infectious Diseases 74 (6), 983-992, 2022 | 12 | 2022 |
| Real-world uptake of COVID-19 vaccination among individuals expressing vaccine hesitancy: a registry-linkage study KL Andrejko, JF Myers, N Fukui, L Nelson, R Zhao, J Openshaw, JP Watt, ... Vaccine 41 (10), 1649-1656, 2023 | 11 | 2023 |
| Waning of 2-dose BNT162b2 and mRNA-1273 vaccine effectiveness against symptomatic SARS-CoV-2 infection accounting for depletion-of-susceptibles bias KL Andrejko, JM Pry, JF Myers, M Mehrotra, K Lamba, E Lim, N Fukui, ... American journal of epidemiology 192 (6), 895-907, 2023 | 9* | 2023 |
| Receipt of COVID-19 and seasonal influenza vaccines in California (USA) during the 2021–2022 influenza season KL Andrejko, JF Myers, J Openshaw, N Fukui, S Li, JP Watt, EL Murray, ... Vaccine 41 (6), 1190-1197, 2023 | 9 | 2023 |
| Longitudinal social contacts among school-aged children during the COVID-19 pandemic: the Bay Area Contacts among Kids (BACK) study KL Andrejko, JR Head, JA Lewnard, JV Remais BMC infectious diseases 22 (1), 242, 2022 | 9 | 2022 |
| Association of pneumococcal serotype with susceptibility to antimicrobial drugs: a systematic review and meta-analysis K Andrejko, B Ratnasiri, JA Lewnard Clinical Infectious Diseases, 2021 | 7 | 2021 |
| WHO Technical Expert Consultation Report on Optimization of PCV Impact: Review of Evidence and Programmatic Considerations to Inform Policy K Andrejko, D Hosangadi, O Cohen, C Adam L, BA Flasche, P McIntyre, ... | 6* | 2017 |
| Contribution and quality of mathematical modeling evidence in world health organization guidelines: A systematic review NC Lo, K Andrejko, P Shukla, T Baker, VI Sawin, SL Norris, JA Lewnard Epidemics 39, 100570, 2022 | 5 | 2022 |
| Biodigester Cookstove Interventions and Child Diarrhea in Semirural Nepal: A Causal Analysis of Daily Observations HK Amato, C Hemlock, KL Andrejko, AR Smith, NS Hejazi, AE Hubbard, ... Environmental Health Perspectives 130 (1), 2022 | 5 | 2022 |
| Outpatient Visits and Antibiotic Use Due to Higher-Valency Pneumococcal Vaccine Serotypes LM King, KL Andrejko, S Kabbani, SY Tartof, LA Hicks, AL Cohen, ... The Journal of Infectious Diseases, jiae142, 2024 | 2* | 2024 |
| Effectiveness of 13-valent pneumococcal conjugate vaccine for prevention of invasive pneumococcal disease among children in the United States between 2010 and 2019: An indirect … KL Andrejko, R Gierke, JV Rowlands, JB Rosen, A Thomas, ZQ Landis, ... Vaccine, 2024 | | 2024 |
Joseph LewnardAssociate Professor, University of California, BerkeleyVerified email at berkeley.edu
